SecBot SecBot
SECBOTREPLAY Home › Report › IINN

IINN · Inspira Technologies announced the deployment of its FDA-cleared ART100…

Inspira Technologies · PRESS-RELEASE filed Feb 18, 2026 at 08:32 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Feb 18, 2026 at 08:32 ET

Inspira Technologies announced the deployment of its FDA-cleared ART100 system at a top-ranked academic medical center in New York for a structured commercial evaluation. This expands its presence in the U.S. Tier-1 hospital market, supporting its commercial strategy, though no financial terms or outcomes were disclosed.

  • Inspira Technologies deployed its ART100 system at a new U.S. academic medical center in New York.
  • The institution is ranked among New York State’s top 10 hospitals in Newsweek’s World’s Best Hospitals 2025.
  • The deployment is part of a structured commercial evaluation to assess clinical protocols and potential broader adoption.
  • No financial figures, revenue impact, or contractual terms were disclosed.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access